An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Study Data Support Efficacy of Treatment for Vasomotor Symptoms Associated with Menopause As reported in the Sept. 6 Pharma Fridays, Bayer will present detailed results from the Phase III study OASIS 3, providing supporting efficacy data and sustained safety data over […]
Pharma Fridays – September 13, 2024
Join the Global Movement Advancing Endocrine Science and Medicine
Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.